Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program. Academic Article uri icon

Overview

abstract

  • Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP). Fifty-three participants started therapy, and 91% achieved sustained virologic response. SSPs provide an effective venue for HCV treatment.

publication date

  • March 6, 2018

Identity

PubMed Central ID

  • PMC5887278

Scopus Document Identifier

  • 85052882378

Digital Object Identifier (DOI)

  • 10.1093/ofid/ofy048

PubMed ID

  • 29644246

Additional Document Info

volume

  • 5

issue

  • 4